The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study
- PMID: 15738453
- DOI: 10.7326/0003-4819-142-5-200503010-00009
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study
Abstract
Background: Hypertension is a risk factor for progression of chronic kidney disease. The optimal blood pressure to slow progression is unknown.
Objective: To evaluate the effects of a low target blood pressure on kidney failure and all-cause mortality.
Design: Long-term follow-up of the Modification of Diet in Renal Disease Study, a randomized, controlled trial conducted from 1989 to 1993.
Setting: 15 outpatient nephrology practices.
Participants: 840 persons with predominantly nondiabetic kidney disease and a glomerular filtration rate of 13 to 55 mL/min per 1.73 m2.
Intervention: A low target blood pressure (mean arterial pressure < 92 mm Hg) or a usual target blood pressure (mean arterial pressure < 107 mm Hg).
Measurements: After the randomized trial was completed, kidney failure (defined as initiation of dialysis or kidney transplantation) and a composite outcome of kidney failure or all-cause mortality were ascertained through 31 December 2000.
Results: Kidney failure occurred in 554 participants (66%), and the composite outcome occurred in 624 participants (74%). After Cox proportional hazards modeling and intention-to-treat analysis, the adjusted hazard ratios were 0.68 (95% CI, 0.57 to 0.82; P < 0.001) for kidney failure and 0.77 (CI, 0.65 to 0.91; P = 0.0024) for the composite outcome in the low target blood pressure group compared with the usual target blood pressure group. Evidence was insufficient to conclude that the benefit of a low target blood pressure differed according to the cause of kidney disease, baseline glomerular filtration rate, or degree of proteinuria.
Limitations: The exact mechanism underlying the benefit of a low target blood pressure is unknown.
Conclusions: Assignment to a low target blood pressure slowed the progression of nondiabetic kidney disease in patients with a moderately to severely decreased glomerular filtration rate.
Comment in
-
Summaries for patients. A low blood pressure target prevented kidney failure in patients with chronic kidney disease.Ann Intern Med. 2005 Mar 1;142(5):I42. doi: 10.7326/0003-4819-142-5-200503010-00004. Ann Intern Med. 2005. PMID: 15738448 No abstract available.
-
Summaries for patients. Ultrasonography to diagnose giant-cell arteritis.Ann Intern Med. 2005 Mar 1;142(5):I44. doi: 10.7326/0003-4819-142-5-200503010-00005. Ann Intern Med. 2005. PMID: 15738449 No abstract available.
-
Target blood pressure and kidney disease.Ann Intern Med. 2005 Aug 16;143(4):310-1; author reply 311. doi: 10.7326/0003-4819-143-4-200508160-00018. Ann Intern Med. 2005. PMID: 16103479 No abstract available.
-
Target blood pressure and kidney disease.Ann Intern Med. 2005 Aug 16;143(4):310; author reply 311. doi: 10.7326/0003-4819-143-4-200508160-00017. Ann Intern Med. 2005. PMID: 16103480 No abstract available.
Similar articles
-
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.Ann Intern Med. 1995 Nov 15;123(10):754-62. doi: 10.7326/0003-4819-123-10-199511150-00003. Ann Intern Med. 1995. PMID: 7574193 Clinical Trial.
-
Summaries for patients. A low blood pressure target prevented kidney failure in patients with chronic kidney disease.Ann Intern Med. 2005 Mar 1;142(5):I42. doi: 10.7326/0003-4819-142-5-200503010-00004. Ann Intern Med. 2005. PMID: 15738448 No abstract available.
-
The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.N Engl J Med. 1994 Mar 31;330(13):877-84. doi: 10.1056/NEJM199403313301301. N Engl J Med. 1994. PMID: 8114857 Clinical Trial.
-
Treatment of hypertension in chronic kidney disease.Semin Nephrol. 2005 Nov;25(6):435-9. doi: 10.1016/j.semnephrol.2005.05.016. Semin Nephrol. 2005. PMID: 16298269 Review.
-
Preventing renal disease progression: is it the drug or the blood pressure reduction, or both?Curr Hypertens Rep. 2000 Dec;2(6):497-9. doi: 10.1007/s11906-996-0030-y. Curr Hypertens Rep. 2000. PMID: 11062593 Review. No abstract available.
Cited by
-
Elucidating the complex interplay between chronic kidney disease and hypertension.Hypertens Res. 2024 Oct 16. doi: 10.1038/s41440-024-01937-8. Online ahead of print. Hypertens Res. 2024. PMID: 39415028 Review.
-
Education programmes for people with chronic kidney disease and diabetes.Cochrane Database Syst Rev. 2024 Aug 22;8(8):CD007374. doi: 10.1002/14651858.CD007374.pub3. Cochrane Database Syst Rev. 2024. PMID: 39171639 Review.
-
Association of the Intensive Blood Pressure Target and Cardiovascular Outcomes in the Population With Chronic Kidney Disease: A Retrospective Study in Korea.J Am Heart Assoc. 2024 Mar 19;13(6):e032186. doi: 10.1161/JAHA.123.032186. Epub 2024 Mar 12. J Am Heart Assoc. 2024. PMID: 38471824 Free PMC article.
-
A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension.Nephrol Dial Transplant. 2024 May 31;39(6):929-943. doi: 10.1093/ndt/gfae041. Nephrol Dial Transplant. 2024. PMID: 38365947 Free PMC article.
-
The long-term benefits of early intensive therapy in chronic diseases-the legacy effect.Clin Kidney J. 2023 Aug 10;16(11):1917-1924. doi: 10.1093/ckj/sfad186. eCollection 2023 Nov. Clin Kidney J. 2023. PMID: 37915902 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical